Mara Goldstein
About Mara Goldstein
Mara Goldstein serves as the Director of Research and Biotechnology Analyst at Clear Street, where she focuses on creating a comprehensive platform for various asset classes. She has extensive experience in the financial services sector, having held senior roles at Thomson Reuters, Mizuho, and Cantor Fitzgerald.
Work at Clear Street
Mara Goldstein serves as the Director of Research and Biotechnology Analyst at Clear Street. In this role, she is involved in the development of a unified platform designed to accommodate every asset class, across all countries, and in any currency. This initiative aims to enhance the efficiency and accessibility of financial services.
Previous Experience in Financial Services
Prior to her current position, Goldstein held significant roles in various financial institutions. She worked at Cantor Fitzgerald as Senior Managing Director and Director of Research from 2011 to 2018. Following this, she served as Managing Director and Biotechnology Analyst at Mizuho from 2018 until 2024. Additionally, she was the Director of Research at Thomson Reuters for three years from 2006 to 2009.
Education and Expertise
Mara Goldstein earned her Bachelor of Science degree in Economics from Purdue University. Her academic background supports her expertise in minimizing risk, redundancy, and cost for clients in the financial services sector. She also specializes in modernizing brokerage ecosystems through cloud-native solutions.
Focus on Risk Management
Goldstein focuses on strategies that minimize risk and redundancy while reducing costs for clients in the financial services industry. Her analytical skills and experience in biotechnology contribute to her ability to navigate complex financial landscapes effectively.